Shortages impacting access to glucagon-like peptide 1 receptor agonist products; increasing the potential for falsified versions

Medicine shortage is a global issue impacting all countries but disproportionality affecting low- and middle-income countries. Since September 2021, the number of molecules reported to be in shortage in two or more countries has increased 101%. Such shortages of medicines are a recognized driving force of falsified or substandard medicines and have the risk of many seeking to source medicines through nonofficial means such as via the internet.

Click here to access the article.